Haemonetics Corporation (HAE) Q4 2014 Earnings Results

Haemonetics Corporation Misses on EPS — Stock Down 6.2%

The earnings report indicates that Haemonetics Corporation struggled to meet expectations, particularly in EPS, which fell short by 20.83%. The stock reacted negatively, dropping 6.2% in response to the results. Investors may be concerned about the company's ability to improve performance in the current market environment, especially given the lack of guidance from management.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$0.46	N/A	-20.83%

Management

Management commentary

Tone: Defensive

Management expressed concerns about the current market conditions impacting performance. They are prioritizing operational improvements to navigate these challenges.

Management acknowledged the challenges faced in the quarter.

They emphasized a focus on improving operational efficiency moving forward.

Haemonetics Corporation Misses on EPS — Stock Down 6.2%

Key numbers

Management commentary

Haemonetics Corporation

More earnings this week

Haemonetics Corporation Misses on EPS — Stock Down 6.2%

Key numbers

Management commentary